Real-life Data of Constitutional Von Willebrand Disease in Western France

Last updated: March 25, 2025
Sponsor: Nantes University Hospital
Overall Status: Completed

Phase

N/A

Condition

N/A

Treatment

no intervention

Clinical Study ID

NCT04887324
RC21_0188
  • All Genders

Study Summary

The objective of this observational study HOPSCOTcH-WILL II is to provide an accurate and detailed account of current Von Willebrand Disease (VWD) therapeutic management by collecting real-life data on hemorrhagic treated events in the 5 Western French Hemophilia Treatment Center.

The HOPSCOTCH-WILL II study aims to describe therapeutic management of patients with VWD, following the provision of a recombinant drug in France; It will also permit to carry out a budget impact analysis to quantify the economic significance of this new era.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Constitutional Von Willebrand Disease patient, of any severity, with or without VonWillebrand Factors inhibitors

  • Patient included in the research database BERHLINGO

  • Patient treated or not by desmopressin or Von Willebrand Factor/FVIII/by-passingagents available on the French market (at baseline)

  • Patient who agrees to participate in the HOPSCOTcH-Will II and followed in one ofthe 5 investigator centers

Exclusion

Exclusion Criteria:

  • Patients under guardianship

Study Design

Total Participants: 922
Treatment Group(s): 1
Primary Treatment: no intervention
Phase:
Study Start date:
July 07, 2023
Estimated Completion Date:
December 31, 2024

Connect with a study center

  • CHU Angers

    Angers,
    France

    Site Not Available

  • CHR de Brest

    Brest,
    France

    Site Not Available

  • CH Le Mans

    Le Mans,
    France

    Site Not Available

  • CHU de Nantes

    Nantes,
    France

    Site Not Available

  • CHU Rennes

    Rennes,
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.